← Leaderboards
Jeremiah J Morrissey
Barnes-Jewish Hospital
$4,100,032
Attributed
$4,668,859
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $537.4K · FY2007–22$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,668,859 · 5
By mechanism
R01$2,595,420 · 1
R21$1,514,011 · 3
P01$559,428 · 1
Top collaborators
- Srikanth Singamaneni6 shared
Others in their field
Top investigators on “Accounting”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$185,928,938
- Zeljko Ivezic · University Of Washington$142,654,512
- Victor Krabbendam · Association Of Universities For Research In Astronomy, Inc.$142,654,512
- Steven M Kahn · Association Of Universities For Research In Astronomy, Inc.$142,654,512
Research focus
AccountingMalignant NeoplasmsBaseUrineDiagnosticEnzyme-Linked Immunosorbent AssayCostAntibodiesDetectionProteinsRenal CarcinomaInnovationNeoplasm MetastasisEarly DiagnosisBiological MarkersKidneyValidationStructureSamplingOperative Surgical ProceduresMolecular MarkerRecoveryCellsLaboratories
Grant awards (19)
Multifunctional Nanoprobe for Early Appraisal of Immunotherapeutic Efficacy$196,875
R21 · FY2022 · EB
Multifunctional Nanoprobe for Early Appraisal of Immunotherapeutic Efficacy$236,250
R21 · FY2021 · EB
METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION$171,281
R21 · FY2021 · CA
METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION$171,190
R21 · FY2020 · CA
METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION$157,500
R21 · FY2020 · CA
NANOTECH BIOMARKERS FOR RENAL CANCER INTERVENTION: CLINICAL VALIDATION & UTILITY$332,831
R01 · FY2019 · CA · contact PI
METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION$204,559
R21 · FY2019 · CA
NANOTECH BIOMARKERS FOR RENAL CANCER INTERVENTION: CLINICAL VALIDATION & UTILITY$343,125
R01 · FY2018 · CA · contact PI
NANOTECH BIOMARKERS FOR RENAL CANCER INTERVENTION: CLINICAL VALIDATION & UTILITY$343,125
R01 · FY2017 · CA · contact PI
NANOTECH BIOMARKERS FOR RENAL CANCER INTERVENTION: CLINICAL VALIDATION & UTILITY$343,125
R01 · FY2016 · CA · contact PI
URINARY BIOMARKERS OF RENAL CELL CARCINOMAS$305,938
R01 · FY2014 · CA · contact PI
URINARY BIOMARKERS OF RENAL CELL CARCINOMAS$296,476
R01 · FY2013 · CA · contact PI
URINARY BIOMARKERS OF RENAL CELL CARCINOMAS$315,400
R01 · FY2012 · CA · contact PI
URINARY BIOMARKERS OF RENAL CELL CARCINOMAS$315,400
R01 · FY2011 · CA · contact PI
The Role of Bone Morphogenetic Protein-7 in Renal Endothelial Cell Biology$186,200
R21 · FY2008 · DK · contact PI
The Role of Bone Morphogenetic Protein-7 in Renal Endothelial Cell Biology$190,156
R21 · FY2007 · DK · contact PI
CORE--LABORATORY$186,476
P01 · FY2002 · DK
CORE--LABORATORY$186,476
P01 · FY2001 · DK
CORE--LABORATORY$186,476
P01 · FY2000 · DK